These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 2982959

  • 1. Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world.
    Sabin AB.
    J Infect Dis; 1985 Mar; 151(3):420-36. PubMed ID: 2982959
    [Abstract] [Full Text] [Related]

  • 2. Strategies for elimination of poliomyelitis in different parts of the world with use of oral poliovirus vaccine.
    Sabin AB.
    Rev Infect Dis; 1984 Mar; 6 Suppl 2():S391-6. PubMed ID: 6740079
    [Abstract] [Full Text] [Related]

  • 3. Perspectives on rapid elimination and ultimate global eradication of paralytic poliomyelitis caused by polioviruses.
    Sabin AB.
    Eur J Epidemiol; 1991 Mar; 7(2):95-120. PubMed ID: 1646116
    [Abstract] [Full Text] [Related]

  • 4. Vaccine control of poliomyelitis in the 1980s.
    Sabin AB.
    Yale J Biol Med; 1982 Mar; 55(3-4):383-9. PubMed ID: 7180028
    [Abstract] [Full Text] [Related]

  • 5. Anomalous observations on IPV and OPV vaccination.
    John TJ.
    Dev Biol (Basel); 2001 Mar; 105():197-208. PubMed ID: 11763328
    [Abstract] [Full Text] [Related]

  • 6. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan 24; 46(RR-3):1-25. PubMed ID: 9026708
    [Abstract] [Full Text] [Related]

  • 7. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
    Moĭseieva HV, Zadorozhna VI.
    Lik Sprava; 2002 Jan 24; (2):85-8. PubMed ID: 12073271
    [Abstract] [Full Text] [Related]

  • 8. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.
    Friedrich F.
    Acta Virol; 2000 Apr 24; 44(2):109-17. PubMed ID: 10989702
    [Abstract] [Full Text] [Related]

  • 9. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V, Kyriakopoulou Z, Markoulatos P.
    Expert Rev Vaccines; 2012 May 24; 11(5):609-28. PubMed ID: 22827246
    [Abstract] [Full Text] [Related]

  • 10. Paralytic poliomyelitis: Old dogmas and new perspectives.
    Sabin AB.
    Rev Infect Dis; 1981 May 24; 3(3):543-64. PubMed ID: 6269169
    [Abstract] [Full Text] [Related]

  • 11. [VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS IN RUSSIAN FEDERATION DURING THE PERIOD OF CHANGES IN VACCINATION SCHEDULE (2006-2013 yy.)].
    Ivanova OE, Eremeeva TP, Morozova NS, Shakaryan AK, Gmyl AP, Yakovenko ML, Korotkova EA, Chernjavskaja OP, Baykova OY, Silenova OV, Krasota AY, Krasnoproshina LI, Mustafina AN, Kozlovskaja LI.
    Vopr Virusol; 2016 May 24; 61(1):9-15. PubMed ID: 27145594
    [Abstract] [Full Text] [Related]

  • 12. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
    Korotkova EA, Gmyl AP, Yakovenko ML, Ivanova OE, Eremeeva TP, Kozlovskaya LI, Shakaryan AK, Lipskaya GY, Parshina IL, Loginovskikh NV, Morozova NS, Agol VI.
    J Virol; 2016 Jul 01; 90(13):5978-88. PubMed ID: 27099315
    [Abstract] [Full Text] [Related]

  • 13. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus.
    Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib Z, André J, Blackman E, Freeman CJ, Jorba J, Sutter R, Tambini G, Venczel L, Pedreira C, Laender F, Shimizu H, Yoneyama T, Miyamura T, van Der Avoort H, Oberste MS, Kilpatrick D, Cochi S, Pallansch M, de Quadros C.
    Science; 2002 Apr 12; 296(5566):356-9. PubMed ID: 11896235
    [Abstract] [Full Text] [Related]

  • 14. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA, Committee on Infectious Diseases.
    Pediatrics; 2015 Jan 12; 135(1):196-202. PubMed ID: 25548328
    [Abstract] [Full Text] [Related]

  • 15. Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand.
    Huang QS, Greening G, Baker MG, Grimwood K, Hewitt J, Hulston D, van Duin L, Fitzsimons A, Garrett N, Graham D, Lennon D, Shimizu H, Miyamura T, Pallansch MA.
    Lancet; 2015 Jan 12; 366(9483):394-6. PubMed ID: 16054940
    [Abstract] [Full Text] [Related]

  • 16. Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes.
    Thompson KM, Duintjer Tebbens RJ.
    BMC Infect Dis; 2015 Sep 17; 15():374. PubMed ID: 26381878
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ.
    Bull World Health Organ; 2004 Jan 17; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [Abstract] [Full Text] [Related]

  • 20. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M, Bandyopadhyay AS, Villena R, Espinoza M, Novoa J, Weldon WC, Oberste MS, Self S, Borate BR, Asturias EJ, Clemens R, Orenstein W, Jimeno J, Rüttimann R, Costa Clemens SA, Chilean IPV/bOPV study group.
    Lancet Infect Dis; 2015 Nov 17; 15(11):1273-82. PubMed ID: 26318714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.